These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9160598)

  • 1. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
    Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
    Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
    [No Abstract]   [Full Text] [Related]  

  • 2. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
    Sheehan DV; Sheehan KH; Raj BA
    Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V; Uhlenhuth EH
    Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
    [No Abstract]   [Full Text] [Related]  

  • 4. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H; Verburg K; Hauzer R; Meijer J; Griez E
    Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
    Lydiard RB; Lesser IM; Ballenger JC; Rubin RT; Laraia M; DuPont R
    J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High doses alprazolam induced amenorrhoea and galactorrhoea.
    Petrić D; Peitl MV; Peitl V
    Psychiatr Danub; 2011 Mar; 23(1):123-4. PubMed ID: 21448116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical picture and treatment of agoraphobia with panic disorder].
    Litvintsev SV; Reznik AM; Kvashnina NV; Arbuzov AL; Krylov KE
    Voen Med Zh; 2003 Jun; 324(6):53-9. PubMed ID: 12916423
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of panic disorder and agoraphobia with clonazepam.
    Spier SA; Tesar GE; Rosenbaum JF; Woods SW
    J Clin Psychiatry; 1986 May; 47(5):238-42. PubMed ID: 3700341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
    Lesser IM; Lydiard RB; Antal E; Rubin RT; Ballenger JC; DuPont R
    Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of alprazolam sublingual tablets in the treatment of the acute phase of panic disorders.
    Márquez M; Arenoso H; Caruso N
    Actas Esp Psiquiatr; 2011; 39(2):88-94. PubMed ID: 21404147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanax XR for panic disorder.
    Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapeutic considerations in anxiety disorders.
    Hollister LE
    J Clin Psychiatry; 1986 Jun; 47 Suppl():33-6. PubMed ID: 2872208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alprazolam treatment for panic disorders.
    Alexander PE; Alexander DD
    J Clin Psychiatry; 1986 Jun; 47(6):301-4. PubMed ID: 2872205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gepirone and the treatment of panic disorder: an open study.
    Pecknold JC; Luthe L; Scott-Fleury MH; Jenkins S
    J Clin Psychopharmacol; 1993 Apr; 13(2):145-9. PubMed ID: 8096526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of panic disorder. Reply to comment by Marks and associates.
    Klerman GL
    Br J Psychiatry; 1992 Oct; 161():465-71. PubMed ID: 1309180
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching patients from alprazolam to clonazepam.
    Rosenbaum JF
    Hosp Community Psychiatry; 1990 Dec; 41(12):1302, 1305. PubMed ID: 2276722
    [No Abstract]   [Full Text] [Related]  

  • 19. Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
    Klein E; Malel D; Zilberman I; Lenox RH
    Isr J Psychiatry Relat Sci; 1997; 34(4):265-9. PubMed ID: 9409083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional classification of anxiety-panic.
    Liebowitz MR
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():47-52. PubMed ID: 7902853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.